Quantitative Assessment of Walking (Squawk) With the Canary canturioTM te (CTE) Tibial Extension
Launched by CANARY MEDICAL · Jan 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Quantitative Assessment of Walking (Squawk)," is looking at how well a new device, the Canary canturio™ te (CTE) Tibial Extension, can detect limping in patients with knee arthritis. The goal is to see if this device can accurately identify a limp compared to assessments made by healthcare providers. If you are over 18 years old, have knee arthritis, and are scheduled for a specific knee implant procedure, you might be eligible to participate in this study.
Participants in the trial will have follow-up appointments to monitor their progress and provide feedback on their experience. It's important to note that individuals who have certain health conditions, such as severe mental health issues or recent knee surgeries, cannot take part in the study. By joining, you'll be contributing to research that could improve treatment options for people with knee arthritis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patient must be 18 years of age or older
- • Independent of study participation, patient is indicated for a commercially available PIQ TKA implant in accordance with product labeling
- • Patient must be willing and able to complete the protocol required follow-up
- • Patient has participated in the study-related informed consent process
- • Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved informed consent
- Exclusion Criteria:
- • • Simultaneous bilateral TKA
- • Staged bilateral TKA less than 6 months from indexed procedure
- • Patient is a current alcohol or drug abuser
- • Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.)
- • Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program
- • Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions
- • Patient with Neuropathic Arthropathy
- • Patient with any loss of musculature or neuromuscular disease that compromises the affected limb
- • Patients with known symptomatic foot, hip or spinal injuries and/or conditions that could affect gait
About Canary Medical
Canary Medical is a pioneering clinical trial sponsor dedicated to advancing innovative medical solutions through robust research and development. Focused on enhancing patient outcomes, the organization specializes in the design, execution, and management of clinical trials across various therapeutic areas. With a commitment to rigorous scientific standards and regulatory compliance, Canary Medical leverages cutting-edge technology and a collaborative approach to facilitate the efficient translation of groundbreaking therapies from the lab to the clinic, ultimately aiming to improve healthcare delivery and patient quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Spartanburg, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials